title: Anti-VEGF therapy for choroidal neovascularisation secondary to Birdshot chorioretinopathy.
authors.affiliation: Moorfields Eye Hospital, Medical retina department, London, United Kingdom. oueghla_eve@hotmail.com
authors.forename: E
authors.initials: E
authors.lastname: Oueghlani
authors.forename: M
authors.initials: M
authors.lastname: Westcott
authors.forename: C E
authors.initials: CE
authors.lastname: Pavésio
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002825:Chorioretinitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab